INDIAN PHARMACEUTICAL ALLIANCE(FORMERLY INDIAN PHARMACEUTICAL ASSOCIATION)

Lobbying Spend

—

Filings

Firms Hired

Active Period

2024–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	4	1
2025	—	4	1
2024	—	9	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
MEDSECUREAN.COM	—	17

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	15
Health & Human Services, Dept of (HHS)	15
SENATE	15
White House Office	15
Food & Drug Administration (FDA)	13
State, Dept of (DOS)	13
U.S. Trade Representative (USTR)	13
Natl Security Council (NSC)	11
Centers For Medicare and Medicaid Services (CMS)	10
Federal Trade Commission (FTC)	7
Commerce, Dept of (DOC)	6
Natl Economic Council (NEC)	4
Office of Management & Budget (OMB)	4
Treasury, Dept of	4
Bureau of Industry and Security (BIS)	2

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	17
Trade (domestic/foreign)	Trade (domestic/foreign)	15
Homeland Security	Homeland Security	8
Defense	Defense	8
Disaster Planning/Emergencies	Disaster Planning/Emergencies	1
Medicare/Medicaid	Medicare/Medicaid	1

INDIAN PHARMACEUTICAL ALLIANCE(FORMERLY INDIAN PHARMACEUTICAL ASSOCIATION) — Lobbying Disclosure | Poliscope